Prostatic acid phosphatase

Source: Wikipedia, the free encyclopedia.
ACP3
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_001099
NM_001134194
NM_001292037

NM_019807
NM_207668

RefSeq (protein)

NP_001090
NP_001127666
NP_001278966

NP_062781
NP_997551

Location (UCSC)Chr 3: 132.32 – 132.37 MbChr 9: 104.17 – 104.21 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Prostatic acid phosphatase (PAP), also prostatic specific acid phosphatase (PSAP), is an enzyme produced by the prostate. It may be found in increased amounts in men who have prostate cancer or other diseases.

The highest levels of acid phosphatase are found in metastasized prostate cancer. Diseases of the bone, such as

, will show moderately increased levels.

Certain

rectal exam
before a test may increase the level.

Its physiological function may be associated with the liquefaction process of semen.[5]

Use in prostatic cancer prognosis

Serum marker

PAP was used to monitor and assess progression of

prostate specific antigen (PSA), which has now largely displaced it. Subsequent work, suggested that it has a role in prognosticating intermediate and high-risk prostate cancer, and led to renewed interest in it as a biomarker.[6]

Immunohistochemistry

PAP

PSA staining can help differentiate them;[7] prostate adenocarcinoma often stains with PSA and/or PAP, while urothelial carcinoma does not.[citation needed
]

HIV

PAP may play an important role in the transmission of HIV. Researchers at the University of Ulm in Germany found that PAP forms fibers made of amyloid. They called the fibers semen-derived enhancer of virus infection (SEVI) and showed that they capture HIV virions promoting their attachment to target cells. The association of PAP with HIV may increase the ability of the virus to infect human cells "by several orders of magnitude." PAP may be a future target of efforts to combat the spread of HIV infection.[8]

Pain suppression

A study at the University of North Carolina and University of Helsinki suggested that PAP could have potent antinociceptive, antihyperalgesic, and antiallodynic effects that last longer than morphine. One dose of PAP lasted for up to three days, much longer than the five hours gained with a single dose of morphine. When in distress, nerve cells release a chemical known as adenosine triphosphate (ATP) which in turn invokes a painful sensation. ATP is broken down into AMP (adenosine monophosphate), which PAP converts into adenosine, a molecule known to suppress pain.[9][10]

History

PAP was the first useful

tumour marker and emerged in the 1940s and 1950s.[6]

See also

  • Adenocarcinoma not otherwise specified

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000014257Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032561Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. .
  6. ^ .
  7. .
  8. .
  9. Daily Telegraph
  10. .

Further reading

External links